S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.44 (+0.83%)
AAPL   193.10 (-1.33%)
MSFT   370.46 (-1.01%)
META   325.18 (-2.27%)
GOOGL   133.13 (-1.38%)
AMZN   145.86 (-1.06%)
TSLA   239.48 (-1.79%)
NVDA   465.29 (-2.06%)
NIO   7.65 (+3.66%)
BABA   71.26 (-1.22%)
AMD   134.13 (+4.04%)
T   16.65 (-1.60%)
F   11.07 (+0.54%)
MU   77.83 (+3.83%)
CGC   0.73 (-8.65%)
GE   120.18 (-0.34%)
DIS   92.18 (-0.69%)
AMC   7.10 (+2.45%)
PFE   28.58 (-0.69%)
PYPL   59.06 (+0.20%)
XOM   99.69 (+0.14%)
S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.44 (+0.83%)
AAPL   193.10 (-1.33%)
MSFT   370.46 (-1.01%)
META   325.18 (-2.27%)
GOOGL   133.13 (-1.38%)
AMZN   145.86 (-1.06%)
TSLA   239.48 (-1.79%)
NVDA   465.29 (-2.06%)
NIO   7.65 (+3.66%)
BABA   71.26 (-1.22%)
AMD   134.13 (+4.04%)
T   16.65 (-1.60%)
F   11.07 (+0.54%)
MU   77.83 (+3.83%)
CGC   0.73 (-8.65%)
GE   120.18 (-0.34%)
DIS   92.18 (-0.69%)
AMC   7.10 (+2.45%)
PFE   28.58 (-0.69%)
PYPL   59.06 (+0.20%)
XOM   99.69 (+0.14%)
S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.44 (+0.83%)
AAPL   193.10 (-1.33%)
MSFT   370.46 (-1.01%)
META   325.18 (-2.27%)
GOOGL   133.13 (-1.38%)
AMZN   145.86 (-1.06%)
TSLA   239.48 (-1.79%)
NVDA   465.29 (-2.06%)
NIO   7.65 (+3.66%)
BABA   71.26 (-1.22%)
AMD   134.13 (+4.04%)
T   16.65 (-1.60%)
F   11.07 (+0.54%)
MU   77.83 (+3.83%)
CGC   0.73 (-8.65%)
GE   120.18 (-0.34%)
DIS   92.18 (-0.69%)
AMC   7.10 (+2.45%)
PFE   28.58 (-0.69%)
PYPL   59.06 (+0.20%)
XOM   99.69 (+0.14%)
S&P 500   4,622.44 (+0.39%)
DOW   36,404.93 (+0.43%)
QQQ   395.44 (+0.83%)
AAPL   193.10 (-1.33%)
MSFT   370.46 (-1.01%)
META   325.18 (-2.27%)
GOOGL   133.13 (-1.38%)
AMZN   145.86 (-1.06%)
TSLA   239.48 (-1.79%)
NVDA   465.29 (-2.06%)
NIO   7.65 (+3.66%)
BABA   71.26 (-1.22%)
AMD   134.13 (+4.04%)
T   16.65 (-1.60%)
F   11.07 (+0.54%)
MU   77.83 (+3.83%)
CGC   0.73 (-8.65%)
GE   120.18 (-0.34%)
DIS   92.18 (-0.69%)
AMC   7.10 (+2.45%)
PFE   28.58 (-0.69%)
PYPL   59.06 (+0.20%)
XOM   99.69 (+0.14%)

RadNet (RDNT) Stock Price, News & Analysis

$36.00
-0.22 (-0.61%)
(As of 03:57 PM ET)
Compare
Today's Range
$35.22
$36.31
50-Day Range
$25.42
$36.48
52-Week Range
$17.82
$36.73
Volume
205,058 shs
Average Volume
430,963 shs
Market Capitalization
$2.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.00

RadNet MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.2% Downside
$34.00 Price Target
Short Interest
Bearish
3.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
0.76mentions of RadNet in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$451,427 Sold Last Quarter
Proj. Earnings Growth
-14.29%
From $0.42 to $0.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

807th out of 944 stocks

Medical Laboratories Industry

18th out of 19 stocks


RDNT stock logo

About RadNet Stock (NASDAQ:RDNT)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Stock Price History

RDNT Stock News Headlines

U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
What Wall Street expects from RadNet's earnings
RadNet Inc RDNT
Should Value Investors Buy RadNet (RDNT) Stock?
Jim Cramer Says This Major Telecom Stock Is 'Horrendous'
RadNet (RDNT) Q2 Earnings and Revenues Top Estimates
A Preview Of RadNet's Earnings
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/11/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RDNT
Employees
9,067
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$34.00
High Stock Price Target
$42.00
Low Stock Price Target
$30.00
Potential Upside/Downside
-4.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$10.65 million
Pretax Margin
2.49%

Debt

Sales & Book Value

Annual Sales
$1.58 billion
Cash Flow
$3.51 per share
Book Value
$8.57 per share

Miscellaneous

Free Float
65,939,000
Market Cap
$2.46 billion
Optionable
Optionable
Beta
1.79

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 77)
    Chairman, President & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 52)
    Executive VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 37)
    Executive VP of Financial Planning & Analysis and Chief Administrative Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 67)
    President & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 62)
    President & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 60)
    Senior VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 67)
    Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. Gregory Sorensen M.D. (Age 61)
    Executive VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Senior Vice President of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 58)
    Executive VP, Chief Legal Officer & Corporate Secretary














RDNT Stock Analysis - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price target for 2024?

3 analysts have issued 1-year price targets for RadNet's shares. Their RDNT share price targets range from $30.00 to $42.00. On average, they predict the company's stock price to reach $34.00 in the next twelve months. This suggests that the stock has a possible downside of 5.2%.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2023?

RadNet's stock was trading at $18.83 at the start of the year. Since then, RDNT shares have increased by 90.5% and is now trading at $35.87.
View the best growth stocks for 2023 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our RDNT earnings forecast
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) released its earnings results on Wednesday, November, 8th. The medical research company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.08. The medical research company had revenue of $401.97 million for the quarter, compared to analysts' expectations of $391.63 million. RadNet had a net margin of 0.25% and a trailing twelve-month return on equity of 4.16%. The firm's revenue was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.09 earnings per share.

What guidance has RadNet issued on next quarter's earnings?

RadNet updated its FY 2023 earnings guidance on Wednesday, November, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.60 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

Who are RadNet's major shareholders?

RadNet's stock is owned by a number of institutional and retail investors. Top institutional investors include Invesco Ltd. (2.17%), Principal Financial Group Inc. (1.71%), Punch & Associates Investment Management Inc. (1.54%), American Century Companies Inc. (1.10%), Loomis Sayles & Co. L P (0.97%) and Northern Trust Corp (0.95%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:RDNT) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -